Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.18) per share which beat the an

Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the dev

U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 1

Analysts change outlook on top names: Mizuho downgrades PYPL, B of A increases CIEN PT, Needham rais

HC Wainwright & Co. analyst Robert Burns maintains Allogene Therapeutics (NASDAQ:ALLO) with a

Jefferies analyst Roger Song maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and raises

US stocks rise, Nasdaq up 200 points; Tech shares lead gains. Morgan Stanley beats estimates. Allbir

Study Highlights Dagger Technology Showing that an Optimized CD70 CAR has the Potential to Protect A

Bernstein analyst William Pickering maintains Allogene Therapeutics (NASDAQ:ALLO) with a Market P

Argus Research analyst William Pickering maintains Allogene Therapeutics (NASDAQ:ALLO) with a Mar

Citizens analyst Reni J. Benjamin maintains Allogene Therapeutics (NASDAQ:ALLO) with a Market Out

US stock futures mixed, Nasdaq 100 up over 50 points. JPMorgan shares down 3.1% after beating earnin

Top Wall Street analysts have changed their outlook on top names. For full analyst rating changes, i

Baird analyst Jack Allen maintains Allogene Therapeutics (NASDAQ:ALLO) with a Outperform and rai

HC Wainwright & Co. analyst Robert Burns maintains Allogene Therapeutics (NASDAQ:ALLO) with a

Allogene Therapeutics, Inc. (NASDAQ:ALLO) today announced that it intends to offer and sell, in an u

Allogene's ALPHA3 trial shows strong MRD clearance and ctDNA reduction, signaling potential to d

U.S. stocks were mixed on Monday, with the Dow Jones falling over 200 points. Leggett & Platt ro

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the de

IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the de

U.S. stock futures lower, Dow futures down 300 points. Worthington Steel Inc (NYSE: WS) shares fall

Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data.

Piper Sandler analyst Biren Amin maintains Allogene Therapeutics (NASDAQ:ALLO) with a Overweight

U.S. stocks higher as Dow Jones gains 300 points; El Pollo LoCo Holdings jumps 17.6% on better-than-

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.17) per share which beat the an

UBS analyst Michael Yee initiates coverage on Allogene Therapeutics (NASDAQ:ALLO) with a Buy rati

Cellectis shares fell after Allogene cited a favorable arbitration ruling confirming control of cema

Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the dev

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for it

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on F